cbdMD, Inc. (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.
The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities. Third-party laboratory testing is conducted on every batch to verify potency and ensure products are free of THC or within federally approved limits. cbdMD markets both broad-spectrum and isolate-based formulations, targeting consumers seeking natural alternatives for stress relief, sleep support, and post-exercise recovery.
cbdMD’s distribution network spans e-commerce, major online marketplaces, and brick-and-mortar retailers across the United States, with expanding presence in select international markets. The company partners with pharmacies, specialty wellness stores, and veterinarians to broaden its retail footprint, while its direct-to-consumer website serves as a primary channel for product innovation feedback and subscription services.
Since its listing on the NYSE American exchange, cbdMD has pursued strategic product line extensions and marketing collaborations to drive brand awareness. The company emphasizes quality assurance, regulatory compliance, and ongoing research to support the evolving cannabinoid market and to meet consumer demand for trusted CBD solutions.
AI Generated. May Contain Errors.
